| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hadassah Medical Organization |
| Information provided by: | Hadassah Medical Organization |
| ClinicalTrials.gov Identifier: | NCT00328224 |
Purpose
To evaluate the dental status of children using ritalin and suffering from ADHA in comparison to healthy children.
| Condition |
|
Attention Deficit Disorder With Hyperactivity Dental Caries Dental Occlusion, Traumatic |
| MedlinePlus related topics: | Attention Deficit Hyperactivity Disorder Injuries Wounds |
| ChemIDplus related topics: | Methylphenidate hydrochloride Methylphenidate |
| Study Type: | Observational |
| Study Design: | Case Control, Other |
| Official Title: | Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD) |
| Enrollment: | 50 |
| Study Start Date: | May 2006 |
| Study Completion Date: | October 2007 |
In this trial oral and dental status of 30 children (ages 5-12) who suffer from ADHD and treated with ritalin will be evaluated. Parameters that will be checked are the following: DMFT - decay, missing, filling teeth for dental status, GI - gingival index, PI - plaque index for periodontal status. OJ - over jet and OB - over bite for inter-maxillary relations and susceptibility for dental trauma. In addition these parameters will be collected for 30 age and sex match healthy children.
Eligibility
| Ages Eligible for Study: | 5 Years to 12 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
healthy children children with adhd treated with ritalin
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Israel | |||||
| Hadassah Medical Organization, Jerusalem, Israel | |||||
| Jerusalem, Israel, 91120 | |||||
| Hadassah Medical Organization |
| Principal Investigator: | Diana Ram, DMD | Hadassah Medical Organization, Jerusalem, Israel |
| Study Director: | Meir Redlich, DMD,PhD | Hadassah Medical Organization, Jerusalem, Israel |
| Study Director: | Hadas Katz-Sagi, DMD | Hadassah Medical Organization, Jerusalem, Israel |
More Information
| Study ID Numbers: | 230606-HMO-CTIL |
| First Received: | May 18, 2006 |
| Last Updated: | October 31, 2007 |
| ClinicalTrials.gov Identifier: | NCT00328224 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|
|
|
|
